Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Cash | 15.520 | 15.520 | 0.000 |
| Shares | 71.740 | 86.420 | 14.680 |
| Bonds | 11.060 | 11.060 | 0.000 |
| Convertible | 0.350 | 0.350 | 0.000 |
| Preferred | 1.140 | 1.140 | 0.000 |
| Other | 0.190 | 0.250 | 0.060 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 17.682 | 16.865 |
| Price to Book | 2.229 | 2.237 |
| Price to Sales | 1.096 | 1.598 |
| Price to Cash Flow | 10.257 | 9.374 |
| Dividend Yield | 2.105 | 1.476 |
| 5 Years Earnings Growth | 9.696 | 8.289 |
| Name | Net % | Category Average |
|---|---|---|
| Basic Materials | 25.610 | 9.659 |
| Healthcare | 23.240 | 17.201 |
| Consumer Defensive | 19.860 | 9.557 |
| Utilities | 7.070 | 6.286 |
| Consumer Cyclical | 6.790 | 9.509 |
| Industrials | 5.620 | 9.786 |
| Energy | 3.880 | 4.262 |
| Real Estate | 3.350 | 1.602 |
| Communication Services | 2.610 | 12.050 |
| Technology | 1.470 | 16.064 |
| Financial Services | 0.500 | 17.713 |
Number of long holdings: 209
Number of short holdings: 55
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Colgate-Palmolive | US1941621039 | 8.50 | 78.21 | +0.01% | |
| PPL | US69351T1060 | 5.66 | 34.85 | +0.10% | |
| Humana | US4448591028 | 5.25 | 253.60 | -1.29% | |
| Newmont Goldcorp | US6516391066 | 4.93 | 89.56 | -0.10% | |
| United States Treasury Notes 4.5% | - | 4.37 | - | - | |
| IFF | US4595061015 | 4.02 | 66.82 | -0.45% | |
| Seabridge Gold | CA8119161054 | 3.92 | 41.43 | +0.51% | |
| Biomarin Pharma | US09061G1013 | 3.68 | 53.98 | -0.62% | |
| Mercury | US5893781089 | 3.52 | 70.58 | +0.50% | |
| J&J | US4781601046 | 3.44 | 204.11 | -0.59% |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review